Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study.

Zhiyong XieZhilian LiWei DongYuanhan ChenRuizhao LiYanhua WuTing LinYiming TaoHuaban LiangWenjian WangShuangxin LiuZhiming YeWei ShiXinling Liang

Published in: Clinical cardiology (2020)

In PGD patients, MS and concomitant DM are associated with an increased risk for cardiovascular comorbidity. More evidence for the causal link between MS/DM and cardiovascular outcomes is needed to be clarified.

Keyphrases

metabolic syndrome
end stage renal disease
mass spectrometry
multiple sclerosis
ms ms
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
cardiovascular disease
skeletal muscle
endothelial cells
cardiovascular risk factors